What is he best known for?
The fields of study he is best known for:
Richard Jove focuses on Cancer research, STAT3, STAT protein, Signal transduction and Proto-oncogene tyrosine-protein kinase Src.
His Cancer research research incorporates themes from Protein kinase B, Carcinogenesis, Tyrosine kinase and Kinase, Kinase activity.
STAT3 is the subject of his research, which falls under Cell biology.
His STAT protein research is multidisciplinary, incorporating elements of Inhibitor of apoptosis, Transcription factor, SOCS3, Immunology and Tyrosine phosphorylation.
The Signal transduction study combines topics in areas such as Microarray analysis techniques, Protein structure, Breast cancer and Peptidomimetic, Peptide.
Ectopic expression is closely connected to Platelet-derived growth factor receptor in his research, which is encompassed under the umbrella topic of Proto-oncogene tyrosine-protein kinase Src.
His most cited work include:
- The STATs of cancer — new molecular targets come of age (1827 citations)
- STATs in oncogenesis. (1577 citations)
- Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells (1514 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cancer research, STAT3, Cell biology, Proto-oncogene tyrosine-protein kinase Src and Signal transduction.
His Cancer research research integrates issues from Cell growth, Carcinogenesis, Tyrosine kinase, Apoptosis and Kinase.
The various areas that he examines in his STAT3 study include Transcription factor, STAT5 and Tyrosine phosphorylation.
In his study, Fibronectin is inextricably linked to Cell adhesion, which falls within the broad field of Cell biology.
His Proto-oncogene tyrosine-protein kinase Src research incorporates elements of Molecular biology, Epidermal growth factor and Kinase activity.
Richard Jove focuses mostly in the field of STAT protein, narrowing it down to topics relating to STAT6 and, in certain cases, STAT1.
He most often published in these fields:
- Cancer research (55.80%)
- STAT3 (36.46%)
- Cell biology (23.76%)
What were the highlights of his more recent work (between 2007-2018)?
- Cancer research (55.80%)
- STAT3 (36.46%)
- Cell biology (23.76%)
In recent papers he was focusing on the following fields of study:
Richard Jove mainly investigates Cancer research, STAT3, Cell biology, Signal transduction and Kinase.
His Cancer research study combines topics from a wide range of disciplines, such as Cancer, Janus kinase and Androgen receptor.
He studies STAT3, focusing on STAT protein in particular.
His work on Proto-oncogene tyrosine-protein kinase Src, Cancer stem cell and Effector as part of his general Cell biology study is frequently connected to Karyopherin, thereby bridging the divide between different branches of science.
His Signal transduction research is multidisciplinary, incorporating perspectives in Viability assay, Apoptosis, Berbamine and Protein kinase A.
His studies in Kinase integrate themes in fields like Cell culture, Protein kinase B and Nucleophilic substitution.
Between 2007 and 2018, his most popular works were:
- Revisiting STAT3 signalling in cancer: new and unexpected biological functions (1045 citations)
- β1 Integrin Adhesion Enhances IL-6–Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation (158 citations)
- Signal Transducer and Activator of Transcription 3 Is Required for Hypoxia-Inducible Factor-1α RNA Expression in Both Tumor Cells and Tumor-Associated Myeloid Cells (130 citations)
In his most recent research, the most cited papers focused on:
Richard Jove spends much of his time researching Cancer research, Signal transduction, Cell biology, STAT3 and Angiogenesis.
Many of his studies on Cancer research involve topics that are commonly interrelated, such as Cell culture.
He works in the field of Signal transduction, namely Kinase activity.
His biological study focuses on STAT protein.
Within one scientific family, Richard Jove focuses on topics pertaining to Regulation of gene expression under STAT protein, and may sometimes address concerns connected to Janus kinase.
His studies deal with areas such as Tyrosine kinase, Biochemistry and Protein kinase A as well as Angiogenesis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
